Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Market
Sugemalimab approval in China makes it only second drug approved globally for ENKTL: GlobalData
GlobalData forecasts sugemalimab to generate sales of $31 million (patient-based forecast) by 2030 for T-cell lymphomas in China
Dr Reddy’s rolls out Nerivio, drug-free non-invasive migraine management device, in India
Nerivio is the first and only USFDA approved device to use Remote Electrical Neuromodulation (REN) to prevent and treat migraine
Vertex Pharma poised to dominate global gene therapy market with first CRISPR approval: GlobalData
The global cell and gene therapy market is expected to reach $80 billion in 2029, with a high CAGR of 51.6 per cent between 2023…
Verve’s gene-editing therapy trial to lower cholesterol levels opens doors for use in CVDs:…
PCSK9 inhibitors, like VERVE-101, currently holds 20 per cent market share in the acute coronary syndrome market. PCSK9 inhibitors…
Glenmark’s La Shield gets Best Consumer Healthcare Digital Marketing Campaign Award
The campaign ‘Be Sun wise’ leveraged the available online information through dynamic creative optimisation to provide consumers…
NPPA slashes prices on 33 FDCs drugs
This move affects pharma companies like JB Chemicals, Eris Lifesciences, Zydus Healthcare, Cipla, Sun Pharma, Sanofi India, and…
Biocon Biologics gets MHRA approval for YESAFILI, biosimilar Aflibercept
In September, YESAFILI received marketing authorisation approval from the European Commission (EC) for the European Union (EU)
First-in-class DLL3-targeting BiTE could be the next big player in SCLC treatment: GlobalData
The drug is forecast to achieve peak sales of $788 million by 2029
Zydus NCE drugs will see improved market penetration with new partnerships in India: GlobalData
Zydus Lifesciences recently entered into a co-marketing partnership with Sun Pharma for desidustat for anemia associated with CKD…
JB Pharma reports revenue growth of 9 per cent to Rs 882 crores in Q2 FY24
PAT increased by 36 per cent to Rs 151 crores
USV, Biogenomics launch INSUQUICK, biosimilar Insulin Aspart for diabetes treatment
Insuquick will be available in cartridges, vials, and prefilled disposable pens
Myasthenia gravis market to generate sales of $6.7 bn across 7MM by 2032: GlobalData
GlobalData identified the influx of several new disease-modifying therapies (DMTs) within the past two years as the main driver of…
Biocon Biologics signs pact with Eris Lifesciences for divesture of dermatology and nephrology…
Total transaction value of the divestment is Rs 3,660 million, inclusive of working capital conveyed as part of the deal
Lupin launches Rocuronium Bromide Injection in US
It is indicated as an adjunct to general anesthesia to facilitate both rapid sequence and routine tracheal intubation, and to…
Accent Microcell files DRHP with NSE Emerge
The company will use net proceeds from the issue to invest in setting up a new plant at Navagam Kheda in Gujarat; it operates two…
GLP1R-targeting drugs dominate type 2 diabetes pipeline: GlobalData
This indicates a shift from the conventional IR to the GLP1R as the primary target for pioneering T2D treatments
Glenmark gets USFDA nod for Fluphenazine Hydrochloride Tablets USP, 1 mg, 2.5 mg, 5 mg, 10 mg
The tablets will be distributed in the US by Glenmark Pharmaceuticals US
Zydus gets USFDA nod for ZITUVIMET to treat adults with type 2 diabetes
ZITUVIMET contains active ingredients sitagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor, and metformin hydrochloride, a…
Venus Remedies gets Three Star Export House Certificate from Govt of India
Previously, Venus Remedies held the Two Star Export House status, which required meeting export performance criteria of $25…